Trial
NCT03341767
A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Bill and Melinda Gates Foundation; The Emmes Company, LLC; Calibr, a division of Scripps Research; Liverpool School of Tropical Medicine; University of Virginia; Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Condition
Cryptosporidiosis
Intervention
Clofazimine
Why stopped
Insufficient accrual rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-13